Market Cap 245.03M
Revenue (ttm) 128.87M
Net Income (ttm) -38.72M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -30.05%
Debt to Equity Ratio 4.36
Volume 462,152
Avg Vol 199,760
Day's Range N/A - N/A
Shares Out 37.47M
Stochastic %K 9%
Beta 0.62
Analysts Sell
Price Target $9.25

Company Profile

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It offers services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and se...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 952 368 4300
Address:
3515 Lyman Boulevard, Chaska, United States
FonsieTrader
FonsieTrader Mar. 17 at 2:17 PM
$LFCR Potential Bounce Player After a big drop yesterday
0 · Reply
Boomer52
Boomer52 Mar. 17 at 12:30 PM
$LFCR Despite the huge drop, it is just sitting at Support 1 on the weekly chart. I want to see it this is just manipulation and if a reversal starts here. As you can see from the both the daily and weekly charts, SP makes it way back to Pivot and above. P=$7.61
0 · Reply
Boomer52
Boomer52 Mar. 17 at 12:22 PM
$LFCR It dropped nearly $3 since Jan 27 to get to S1. Then in one day it dropped $2 more to get to S3. So it has now fallen over 50%. This drop is not your normal miss earnings drop. This is obviously related to the securities fraud settlement and institutional, hedge funds selling.
1 · Reply
11thestate
11thestate Mar. 17 at 10:38 AM
$LFCR investors, if you follow us, you already know about it. This info hits different after the news. Check it out: https://11th.com/cases/lifecore-investor-settlement
0 · Reply
StockNews_Live
StockNews_Live Mar. 16 at 12:34 PM
$LFCR 🎯 STOCK NEWS ALERT 💵 Price: $6.56 (-1.06%) 🔥 Sentiment Score: 85/100 🚀 VERY POSITIVE NEWS 📄 Lifecore Biomedical reported financial results for the fourth quarter and transition period ended December 31, 2025, with revenues of $35.7 million and $75.5 million, respectively. The company also… 📎 https://stocknews.live/news/LFCR/lifecore-biomedical-reports-financial-32861.html
0 · Reply
DARKP00L
DARKP00L Mar. 16 at 12:06 PM
$LFCR 08:05 on Mar. 16 2026 Lifecore Biomedical Sees FY2026 Sales $120.000M-$125.000M vs $129.846M Est #tradeideas
0 · Reply
11thestate
11thestate Mar. 10 at 1:39 PM
$LFCR investors — there's no hidden secret here. Just one thing you really need to know. Here's how to handle your losses. More importantly, how to either recover them or risk losing even more: https://11th.com/cases/lifecore-investor-settlement
0 · Reply
BillionerOfKing
BillionerOfKing Mar. 10 at 1:22 PM
$LFCR Current Stock Price: $6.97 Contracts to trade: $7.5 LFCR Mar 20 2026 Call Entry: $0.34 Exit: $0.59 ROI: 74% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
focafoca99
focafoca99 Mar. 5 at 10:44 PM
$LFCR came out with shareholder director nominations
0 · Reply
StockNews_Live
StockNews_Live Mar. 4 at 9:07 PM
$LFCR Lifecore Biomedical, Inc. and Indomo announced a new development services agreement for the continued development of Indomo's corticosteroid drug candidate, DT-001. DT-001 will be combined with Indomo…
0 · Reply
Latest News on LFCR
Lifecore Biomedical to Participate at DCAT Week 2026

Feb 17, 2026, 7:05 AM EST - 4 weeks ago

Lifecore Biomedical to Participate at DCAT Week 2026


Lifecore Biomedical: The Turnaround Is Just Getting Started

Jan 1, 2026, 8:50 AM EST - 2 months ago

Lifecore Biomedical: The Turnaround Is Just Getting Started


Lifecore Biomedical to be Added to Nasdaq Biotech Index

Dec 18, 2025, 7:00 AM EST - 3 months ago

Lifecore Biomedical to be Added to Nasdaq Biotech Index


Laughing Water Capital's Top 5 Positions For Q2 2025

Aug 7, 2025, 4:45 AM EDT - 7 months ago

Laughing Water Capital's Top 5 Positions For Q2 2025


Lifecore Biomedical: Inflecting Financials Over Next 3 Years

Jun 18, 2025, 3:27 AM EDT - 9 months ago

Lifecore Biomedical: Inflecting Financials Over Next 3 Years


Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer

May 27, 2025, 7:00 AM EDT - 10 months ago

Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer


Greenhaven Road Capital Main Fund Q1 2025 Top 5 Holdings

May 19, 2025, 9:35 AM EDT - 10 months ago

Greenhaven Road Capital Main Fund Q1 2025 Top 5 Holdings

BUR CLBT KKR PAR


FonsieTrader
FonsieTrader Mar. 17 at 2:17 PM
$LFCR Potential Bounce Player After a big drop yesterday
0 · Reply
Boomer52
Boomer52 Mar. 17 at 12:30 PM
$LFCR Despite the huge drop, it is just sitting at Support 1 on the weekly chart. I want to see it this is just manipulation and if a reversal starts here. As you can see from the both the daily and weekly charts, SP makes it way back to Pivot and above. P=$7.61
0 · Reply
Boomer52
Boomer52 Mar. 17 at 12:22 PM
$LFCR It dropped nearly $3 since Jan 27 to get to S1. Then in one day it dropped $2 more to get to S3. So it has now fallen over 50%. This drop is not your normal miss earnings drop. This is obviously related to the securities fraud settlement and institutional, hedge funds selling.
1 · Reply
11thestate
11thestate Mar. 17 at 10:38 AM
$LFCR investors, if you follow us, you already know about it. This info hits different after the news. Check it out: https://11th.com/cases/lifecore-investor-settlement
0 · Reply
StockNews_Live
StockNews_Live Mar. 16 at 12:34 PM
$LFCR 🎯 STOCK NEWS ALERT 💵 Price: $6.56 (-1.06%) 🔥 Sentiment Score: 85/100 🚀 VERY POSITIVE NEWS 📄 Lifecore Biomedical reported financial results for the fourth quarter and transition period ended December 31, 2025, with revenues of $35.7 million and $75.5 million, respectively. The company also… 📎 https://stocknews.live/news/LFCR/lifecore-biomedical-reports-financial-32861.html
0 · Reply
DARKP00L
DARKP00L Mar. 16 at 12:06 PM
$LFCR 08:05 on Mar. 16 2026 Lifecore Biomedical Sees FY2026 Sales $120.000M-$125.000M vs $129.846M Est #tradeideas
0 · Reply
11thestate
11thestate Mar. 10 at 1:39 PM
$LFCR investors — there's no hidden secret here. Just one thing you really need to know. Here's how to handle your losses. More importantly, how to either recover them or risk losing even more: https://11th.com/cases/lifecore-investor-settlement
0 · Reply
BillionerOfKing
BillionerOfKing Mar. 10 at 1:22 PM
$LFCR Current Stock Price: $6.97 Contracts to trade: $7.5 LFCR Mar 20 2026 Call Entry: $0.34 Exit: $0.59 ROI: 74% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
focafoca99
focafoca99 Mar. 5 at 10:44 PM
$LFCR came out with shareholder director nominations
0 · Reply
StockNews_Live
StockNews_Live Mar. 4 at 9:07 PM
$LFCR Lifecore Biomedical, Inc. and Indomo announced a new development services agreement for the continued development of Indomo's corticosteroid drug candidate, DT-001. DT-001 will be combined with Indomo…
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 3 at 2:31 AM
$LFCR RSI: 41.96, MACD: -0.2013 Vol: 0.36, MA20: 7.40, MA50: 7.87 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
11thestate
11thestate Feb. 27 at 12:19 PM
$LFCR is now accepting claims for a $3,750,000 settlement it is paying to investors over claims that it maintained weak financial controls that led to inaccurate statements and overstated business prospects. If you bought $LFCR between October 7, 2020 and March 19, 2024, you still can file for payment here: https://11th.com/cases/lifecore-investor-settlement
0 · Reply
11thestate
11thestate Feb. 18 at 3:22 PM
$LFCR has agreed to settle with investors over claims that weak internal controls led to inaccurate financial statements and overstated prospects. Who’s eligible? Anyone who purchased $LFCR shares between October 7, 2020 and March 19, 2024. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $0.20 — but normally only about 25% of eligible investors file claims. If that trend holds, the effective payout could rise to approximately $0.80 per share. Can I still file? Yes — the settlement terms have been submitted to the court for approval and claims are expected to be accepted. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/lifecore-investor-settlement
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 16 at 7:49 PM
$LFCR Share Price: $7.08 Contract Selected: Sep 18, 2026 $7.5 Calls Buy Zone: $0.30 – $0.37 Target Zone: $0.54 – $0.66 Potential Upside: 71% ROI Time to Expiration: 213 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
ThanhSurratt914
ThanhSurratt914 Feb. 11 at 2:36 PM
$LFCR Lifecore Biomedical; CDMO and CRO services; restructuring and debt overhang; needs to demonstrate operational stability and organic growth.
0 · Reply
11thestate
11thestate Feb. 6 at 12:51 PM
With everything going on around $LFCR lately — this is the info you don’t want to miss: https://11th.com/cases/lifecore-investor-settlement
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 5 at 1:10 AM
$LFCR Current Stock Price: $7.91 Contracts to trade: $7.5 LFCR Feb 20 2026 Call Entry: $0.35 Exit: $0.45 ROI: 27% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
11thestate
11thestate Jan. 16 at 2:42 PM
$LFCR is now accepting claims for a settlement it is paying to investors over claims that it misled investors about financial controls and business prospects. If you bought $LFCR between October 7, 2020 and March 19, 2024, you still can file for payment here: https://11th.com/cases/lifecore-investor-settlement
0 · Reply
BearTamerTrading
BearTamerTrading Jan. 11 at 11:57 PM
On Watch for JPM Week: Part 2 $MLAB – Mesa Labs – will present on Jan 14, 2026. $AAPG – Ascentage Pharma Group International – announced presentation. $LFCR – Lifecore Biomedical – participating (1-on-1s and meetings).
0 · Reply
11thestate
11thestate Jan. 6 at 2:41 PM
Don't forget that there is also an important settlement to watch for $LFCR We have every detail, including how investors can get paid: https://11th.com/cases/lifecore-investor-settlement
0 · Reply
PrecisionChartist
PrecisionChartist Dec. 27 at 6:14 AM
$LFCR Sentiment increasingly tracks operational truth rather than guidance tone. Governance alignment can reduce perceived uncertainty. Execution consistency is the fastest path to confidence rebuilding. Execution quality becomes the defining catalyst from here.
0 · Reply
11thestate
11thestate Dec. 23 at 2:58 PM
$LFCR investors, if you follow us, you already know about it. This info hits different after the news. Check it out: https://11th.com/cases/lifecore-investor-settlement
0 · Reply